Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Prepaid Assets (2023 - 2025)

Contineum Therapeutics (CTNM) has 3 years of Prepaid Assets data on record, last reported at $2.5 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 104.55% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $2.5 million, up 104.55%, while the annual FY2024 figure was $1.6 million, 35.29% down from the prior year.
  • Prepaid Assets reached $2.5 million in Q3 2025 per CTNM's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.5 million in Q3 2025 and bottomed at $1.2 million in Q3 2024.
  • Average Prepaid Assets over 3 years is $1.8 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: tumbled 35.29% in 2024, then soared 104.55% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $2.5 million in 2023, then tumbled by 35.29% to $1.6 million in 2024, then surged by 54.79% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $2.5 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.